Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort

AIDS

Volumn 21, Issue SUPPL. 6, 2007, Pages

  Isingo, Raphael ^a   Zaba, Basia ^a,b   Marston, Milly ^b   Ndege, Milalu ^a   Mngara, Julius ^a   Mwita, Wambura ^a   Wringe, Alison ^b   Beckles, David ^a   Changalucha, John ^a   Urassa, Mark ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV AIDS; Mortality; Survival; Tanzania

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; COHORT ANALYSIS; COMMUNITY; COMMUNITY CARE; CONFERENCE PAPER; DEATH; DEMOGRAPHY; DEVELOPING COUNTRY; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SEROCONVERSION; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; TANZANIA; UGANDA;

EID: 36348935054     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000298097.64237.4b     Document Type: Conference Paper

References (23)

1. UNAIDS. AIDS epidemic update, December 2006. Available at: http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf. Accessed: April 2007.
2. Porter K, Zaba B. The empirical evidence for the impact of HIV on adult mortality in the developing world: data from serological studies. AIDS 2004; 18 (Suppl. 2):S9-S17.
3. Lopman BA, Barnabas R, Hallett TB, Nyamukapa C, Mundandi C, Mushati P, et al. Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998-2003). Bull WHO 2006; 84:189-197.
4. UNAIDS Reference Group on Estimates, Modelling and Projections. Improved methods and assumptions for estimating the HIV/AIDS epidemic and its impact. AIDS 2002; 16:W1-W14.
5. Anzala OA, Nagelkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-689.
6. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JAG. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16:597-603.
7. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU concerted action. Time from HIV-1 sero-conversion to AIDS and death before the widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355: 1131-1137.
8. Van der Paal L, Shafer LA, Todd J, Mayanja BN, Whitworth JAG, Grosskurth H. HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda. AIDS 2007; 21 (Suppl. 6):S21-S29.
9. Lutalo T, Gray RH, Wawer M, Sewankambo N, Serwadda D, Laeyendecker O, et al. Survival of HIV infected treatment naive persons with known dates of seroconversion in Rakai, Uganda. AIDS 2007; 21 (Suppl. 6):S15-S19.
10. Mwaluko G, Urassa M, Isingo R, Zaba B, Boerma JT. Trends in HIV and sexual behaviour in a longitudinal study in a rural population in Tanzania, 1994-2000. AIDS 2003; 17:2645-2651.
11. Urassa M, Boerma JT, Isingo R, Ngalula J, Ng'weshemi J, Mwaluko G, Zaba B. The impact of HIV/AIDS on mortality and household mobility in rural Tanzania. AIDS 2001; 15:2017-2023.
12. Boerma JT, Urassa M, Nnko S, Ng'weshemi JZL, Isingo R, Zaba B, Mwaluko G. Socio-demographic context of the AIDS epidemic in a rural area in Tanzania with a focus on people's mobility and marriage. Sex Transm Infect 2002; 78 (Suppl. 1): 97-105.
13. Bloom S, Urassa M, Isingo R, Ng'weshemi J, Boerma J. Community effects on the risk of HIV infection in rural Tanzania. Sex Transm Infect 2002; 78:261-266.
14. Law CG, Brookmeyer R. Effect of mid-point imputation on the analysis of double censored data. Stat Med 1992; 11:1569-1578.
15. Mwita W, Urassa M, Isingo R, Ndege M, Marston M, Slaymaker E, et al. HIV prevalence and incidence in rural Tanzania: results from 10 years of follow-up in an open cohort study. J Acquir Immune Defic Syndr 2007; in press.
16. Klein JP, Moeschberger ML. 2003. Survival analysis: techniques for censored and truncated data, 2nd ed. New York: Springer; 2003. pp. 167-168.
17. Marston M, Todd J, Glynn JR, Nelson K, Rangsin R, Lutalo T, et al. Estimating 'net' HIV-related mortality and the importance of background mortality rates. AIDS 2007; 21 (Suppl. 6):S65-S71.
18. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, Mwita W, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21 (Suppl. 6):S55-S63.
19. Kishamawe C, Vissers DC, Urassa M, Isingo R, Mwaluko G, Borsboom GJ, et al. Mobility and HIV in Tanzanian couples: both mobile persons and their partners show increased risk. AIDS 2006; 20:601-608.
20. Kanari Y, Clerici M, Abe H, Kawabata H, Trabattoni D, Capito SL, et al. Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians. AIDS 2005; 19:1015-1024.
21. Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS 2003; 17:2547-2560.
22. Koblin BA, van Benthem BH, Buchbinder SP, Ren L, Vittinghoff E, Stevens CE, et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. Am J Epidemiol 1999; 150:1026-1030.
23. TAZAMA Project, 2007. Phase 2 implementation plan and budget for the monitoring and evaluation component. Report to GFATM. Mwanza, Tanzania: National Institute for Medical Research; 2007.